Clare M. Baecher-Allan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Interleukin-2 | 13 | 2006 | 561 | 1.910 |
Why?
|
| T-Lymphocytes, Regulatory | 17 | 2018 | 3111 | 1.520 |
Why?
|
| Multiple Sclerosis | 12 | 2024 | 3213 | 1.170 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 4 | 2015 | 305 | 1.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 13 | 2018 | 4405 | 0.830 |
Why?
|
| Granzymes | 2 | 2015 | 278 | 0.720 |
Why?
|
| T-Lymphocyte Subsets | 8 | 2011 | 1811 | 0.700 |
Why?
|
| Receptors, Immunologic | 2 | 2024 | 1415 | 0.680 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 4642 | 0.600 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 2 | 2015 | 50 | 0.570 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 3 | 2024 | 550 | 0.540 |
Why?
|
| HLA-DR Antigens | 4 | 2015 | 608 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2023 | 1857 | 0.530 |
Why?
|
| E-Selectin | 1 | 2018 | 576 | 0.500 |
Why?
|
| Flow Cytometry | 8 | 2013 | 5881 | 0.430 |
Why?
|
| Antibodies, Monoclonal | 6 | 2023 | 9249 | 0.420 |
Why?
|
| Lymphocyte Activation | 9 | 2024 | 5501 | 0.350 |
Why?
|
| Immunomagnetic Separation | 2 | 2006 | 78 | 0.320 |
Why?
|
| Cell Separation | 4 | 2010 | 1718 | 0.320 |
Why?
|
| Coculture Techniques | 6 | 2018 | 1336 | 0.310 |
Why?
|
| Immune Tolerance | 6 | 2009 | 2324 | 0.310 |
Why?
|
| Cells, Cultured | 10 | 2024 | 18973 | 0.300 |
Why?
|
| T-Lymphocytes | 11 | 2023 | 10261 | 0.270 |
Why?
|
| Interleukin-6 | 3 | 2021 | 3222 | 0.270 |
Why?
|
| Administration, Intranasal | 3 | 2023 | 482 | 0.270 |
Why?
|
| Self Tolerance | 2 | 2006 | 119 | 0.270 |
Why?
|
| Copyright | 1 | 2005 | 13 | 0.260 |
Why?
|
| Immunotherapy | 3 | 2018 | 4752 | 0.250 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 3078 | 0.240 |
Why?
|
| Medical Illustration | 1 | 2005 | 134 | 0.230 |
Why?
|
| Pulmonary Fibrosis | 3 | 2002 | 503 | 0.230 |
Why?
|
| Cytokines | 6 | 2024 | 7421 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2014 | 2570 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 6 | 2011 | 1624 | 0.200 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2008 | 1441 | 0.200 |
Why?
|
| Muromonab-CD3 | 1 | 2022 | 104 | 0.200 |
Why?
|
| Autoimmune Diseases | 5 | 2014 | 2226 | 0.200 |
Why?
|
| Cryptosporidium parvum | 2 | 2000 | 35 | 0.180 |
Why?
|
| Research Subjects | 1 | 2022 | 247 | 0.180 |
Why?
|
| Immunologic Memory | 4 | 2024 | 1375 | 0.170 |
Why?
|
| Central Nervous System | 3 | 2018 | 1341 | 0.170 |
Why?
|
| Th1 Cells | 2 | 2018 | 1039 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2024 | 11641 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2023 | 637 | 0.160 |
Why?
|
| Antigens, CD | 6 | 2009 | 4025 | 0.160 |
Why?
|
| Peptide Library | 2 | 2000 | 351 | 0.160 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2000 | 445 | 0.160 |
Why?
|
| Antibodies, Protozoan | 1 | 1999 | 250 | 0.150 |
Why?
|
| Myositis, Inclusion Body | 1 | 2019 | 145 | 0.140 |
Why?
|
| Interleukin-10 | 3 | 2010 | 1183 | 0.140 |
Why?
|
| Bleomycin | 4 | 2002 | 491 | 0.140 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2014 | 3733 | 0.130 |
Why?
|
| Humans | 47 | 2024 | 765968 | 0.130 |
Why?
|
| Lectins, C-Type | 1 | 2019 | 592 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2001 | 1188 | 0.130 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1866 | 0.130 |
Why?
|
| Neuroimmunomodulation | 1 | 2018 | 186 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2018 | 473 | 0.130 |
Why?
|
| Chromosome Mapping | 2 | 2009 | 4618 | 0.120 |
Why?
|
| Interleukin-17 | 3 | 2010 | 921 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2015 | 1801 | 0.120 |
Why?
|
| Receptors, Nicotinic | 1 | 2018 | 494 | 0.120 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2010 | 975 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2001 | 981 | 0.110 |
Why?
|
| Animals | 20 | 2023 | 168764 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2023 | 2747 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 1993 | 313 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 1484 | 0.100 |
Why?
|
| Signal Transduction | 9 | 2018 | 23601 | 0.090 |
Why?
|
| Langerhans Cells | 1 | 2012 | 170 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2018 | 786 | 0.090 |
Why?
|
| Ligands | 1 | 2018 | 3273 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1242 | 0.090 |
Why?
|
| Epitopes | 2 | 1997 | 2523 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2013 | 319 | 0.090 |
Why?
|
| Interleukin-9 | 1 | 2010 | 63 | 0.080 |
Why?
|
| Pneumonia | 1 | 2021 | 2157 | 0.080 |
Why?
|
| Epidermis | 1 | 2012 | 538 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 4209 | 0.080 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 11888 | 0.080 |
Why?
|
| Neoplasms | 3 | 2006 | 22340 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 3807 | 0.070 |
Why?
|
| Interleukin-2 | 3 | 2009 | 1896 | 0.070 |
Why?
|
| L-Selectin | 2 | 2005 | 212 | 0.070 |
Why?
|
| Uteroglobin | 2 | 1998 | 55 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2002 | 6220 | 0.070 |
Why?
|
| Clonal Anergy | 1 | 2007 | 169 | 0.070 |
Why?
|
| Celiac Disease | 1 | 2014 | 820 | 0.060 |
Why?
|
| DNA Primers | 3 | 2003 | 2825 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10429 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2140 | 0.060 |
Why?
|
| Cell Division | 3 | 2004 | 4475 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 4778 | 0.060 |
Why?
|
| Mice | 10 | 2023 | 81819 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 318 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4958 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 788 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2009 | 12768 | 0.060 |
Why?
|
| Antibody Specificity | 1 | 2006 | 1061 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2011 | 1369 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 300 | 0.050 |
Why?
|
| Autoimmunity | 2 | 2008 | 1354 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2014 | 18071 | 0.050 |
Why?
|
| Interleukins | 1 | 2008 | 791 | 0.050 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2002 | 40 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5138 | 0.050 |
Why?
|
| Antigens | 2 | 2012 | 1438 | 0.050 |
Why?
|
| Middle Aged | 8 | 2024 | 223009 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2007 | 752 | 0.050 |
Why?
|
| Adult | 8 | 2024 | 223044 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1162 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2014 | 3446 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2000 | 419 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2002 | 200 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2009 | 4137 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 291 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 623 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2011 | 2113 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2015 | 22223 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2006 | 1250 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3421 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1587 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2002 | 517 | 0.040 |
Why?
|
| Cyclothymic Disorder | 1 | 2020 | 44 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 591 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2007 | 2927 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 4348 | 0.040 |
Why?
|
| Pulmonary Surfactants | 2 | 1998 | 169 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2009 | 1995 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4462 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 6069 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2001 | 790 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 541 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 945 | 0.040 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1999 | 290 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18293 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 919 | 0.040 |
Why?
|
| Skin | 1 | 2012 | 4489 | 0.040 |
Why?
|
| Serpins | 1 | 2000 | 245 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2006 | 1044 | 0.040 |
Why?
|
| HIV Infections | 1 | 2004 | 17533 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 1892 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 1067 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 648 | 0.030 |
Why?
|
| Proteolipids | 1 | 1997 | 109 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2002 | 2341 | 0.030 |
Why?
|
| Lung | 3 | 2021 | 10033 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 871 | 0.030 |
Why?
|
| Base Sequence | 2 | 1999 | 12403 | 0.030 |
Why?
|
| Female | 8 | 2024 | 396112 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2002 | 2601 | 0.030 |
Why?
|
| Male | 5 | 2024 | 363698 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1652 | 0.030 |
Why?
|
| Gene Expression | 2 | 2006 | 7584 | 0.030 |
Why?
|
| Isoantigens | 1 | 1997 | 562 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 17594 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 59889 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2009 | 6610 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6274 | 0.030 |
Why?
|
| Membrane Proteins | 3 | 2023 | 7851 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9514 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 813 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1595 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 4528 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1997 | 679 | 0.030 |
Why?
|
| Species Specificity | 2 | 1997 | 2406 | 0.030 |
Why?
|
| Antibodies | 1 | 2000 | 2417 | 0.020 |
Why?
|
| Cell Line | 3 | 2009 | 15543 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 74840 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26346 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3690 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6493 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2163 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2086 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1993 | 1644 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3850 | 0.020 |
Why?
|
| Peptides | 1 | 2001 | 4331 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2009 | 3634 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2011 | 346 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 579 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2009 | 239 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20124 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 834 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8733 | 0.020 |
Why?
|
| Genotype | 2 | 2014 | 13024 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2008 | 151 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2010 | 636 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9601 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3715 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 13632 | 0.020 |
Why?
|
| Fetus | 1 | 1993 | 1870 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2011 | 1555 | 0.020 |
Why?
|
| Transfection | 1 | 1993 | 5743 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 583 | 0.010 |
Why?
|
| Phenotype | 2 | 2014 | 16721 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2411 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 1028 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2009 | 2352 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2011 | 3160 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3481 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 1077 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 1998 | 22332 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4562 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1884 | 0.010 |
Why?
|
| Joints | 1 | 2003 | 321 | 0.010 |
Why?
|
| Homeostasis | 1 | 2012 | 3336 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 2003 | 385 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1657 | 0.010 |
Why?
|
| Immunization | 1 | 2004 | 1219 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2000 | 259 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10603 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 629 | 0.010 |
Why?
|
| Trypsin | 1 | 2000 | 487 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26318 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41649 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 8278 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 88835 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6897 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1724 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1997 | 123 | 0.010 |
Why?
|
| Muramidase | 1 | 1997 | 163 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 3081 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1997 | 359 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18380 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11022 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1998 | 3681 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12807 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16047 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72903 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1886 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9443 | 0.010 |
Why?
|
| Proteins | 2 | 1998 | 5995 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 14751 | 0.010 |
Why?
|
| Epithelium | 1 | 1997 | 1599 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6113 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23707 | 0.010 |
Why?
|
| Pregnancy | 1 | 1993 | 30260 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3404 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1997 | 1303 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2008 | 12131 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5125 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 9550 | 0.000 |
Why?
|
| Aged | 2 | 2009 | 171117 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2000 | 4900 | 0.000 |
Why?
|
| Inflammation | 1 | 2003 | 10850 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 21056 | 0.000 |
Why?
|